Related Experiment Videos
Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors
1Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Chinese University of Hong Kong.
Pathology
|January 1, 1994
Summary
p53 protein alterations are linked to the progression of brain tumors. Aberrant p53 accumulation was observed more frequently in high-grade astrocytomas, particularly in small anaplastic cells, suggesting its role in pathogenesis.
Area of Science:
- Neuro-oncology
- Molecular Pathology
- Cancer Biology
Background:
- p53 protein alterations are implicated in various cancers.
- Understanding p53's role in intracranial neuroectodermal tumors is crucial for pathogenesis characterization.
Purpose of the Study:
- To investigate the role of p53 alterations in the pathogenesis of intracranial neuroectodermal tumors.
- To correlate p53 protein expression with tumor grade and cell type.
Main Methods:
- Immunohistochemical staining of 196 intracranial neuroectodermal tumors using a monoclonal antibody against p53 protein.
- Analysis of archival formalin-fixed, paraffin-embedded tissue samples.
- Correlation of p53 immunolabelling with astrocytoma grade (well-differentiated, anaplastic astrocytoma, glioblastoma multiforme), oligodendrogliomas, medulloblastomas, ependymomas, and choroid plexus tumors.
Main Results:
- Positive p53 staining was observed in 11% of well-differentiated astrocytomas and up to 40% of high-grade astrocytomas.
- Increased p53 immunolabelling correlated with increasing astrocytoma grade.
- Aberrant p53 protein accumulation was predominantly seen in small anaplastic cells within high-grade astrocytomas.
- Oligodendrogliomas and medulloblastomas showed rare positive staining, while ependymomas and choroid plexus tumors were negative.
Conclusions:
- p53 alterations play a significant role in the progression of astrocytomas from low-grade to high-grade.
- Small anaplastic cells are the critical cell type involved in aberrant p53 protein accumulation during astrocytoma progression.
- p53 status may serve as a potential biomarker for tumor progression in neuroectodermal tumors.